The recommended medical treatment for Alzheimer’s disease and many of the other dementias includes a group of drugs that are often called “dementia slowing” or “memory enhancing” medications. The most prescribed include a group of drugs called cholinesterase inhibitors. These go by the trade names of Aricept, Exelon and Razadyne. These drugs do not stop the underlying progress of dementia, but they often support better thinking and memory. The drugs work by boosting a brain chemical that is essential for healthy thinking and functioning. Another drug called Namenda has different neuroprotective properties but also supports better brain functioning. Most persons on Namenda are on one of the three cholinesterase inhibitors and this combination therapy seems to work best.

These four current medications for dementia provide modest benefit. They can temporarily improve symptoms and help a person think better and remain independent longer. Conventional wisdom is that the drugs begin to lose their effectiveness over time. Side effects for these medications are modest and can include stomach/digestive (GI) problems, vivid dreams, and agitation.

A senior with an array of medications.

One of the challenges of these drugs is that they work better for some people than others. Some people taking the medications have noticeable improvement. They might return to the golf course, gain back skills like operating the washing machine or report better memory in general. Others may be benefitting but show no noticeable effect. In these cases the drug or drugs may be helping them maintain their current levels of functioning; this is still a valuable benefit. There are some people who seem to have no apparent benefit from these memory medications.

The British Alzheimer’s Society has a short but helpful summary on its website, “Research suggests that between 40 and 70 per cent of people with Alzheimer’s disease benefit from cholinesterase inhibitor treatment, but it is not effective for everyone and may improve symptoms only temporarily, between 6 and 12 months in most cases. According to an Alzheimer’s Society survey of 4,000 people, those using these treatments often experience improvements in motivation, anxiety levels and confidence, in addition to daily living, memory and thinking.”

The US Alzheimer’s Association endorses these medications. However the Alzheimer’s Association encourages families to maintain realistic expectations, noting that the medicines don’t cure Alzheimer’s or stop it from progressing but may lessen symptoms for a limited time.

Home Instead dementia care consultant David Troxel recalls a time when there were no medications. “However modest their impact, these memory medications have given hope to millions of persons around the world. That being said we desperately need new and better medicines to help people with dementia.”

A frequently asked question at support groups and in other settings is when to stop using the medications. Many physicians will choose to keep a person with dementia on these medications for a long period of time under the theory that even modest benefits are better than nothing. Other physicians will slowly withdraw patients from these drugs if they and the families perceive that the drugs are no longer having a positive impact.

Until we find a truly effective way to prevent, treat or cure Alzheimer’s disease and other dementia David Troxel notes that the “treatment” for dementia is socialization, keeping the person active with exercise, music and creative activities. “Engaging the person in life as much as possible fights depression and keeps him or her operating at their very best.”

Latest Alzheimer's & Other Dementia Treatments

Laurie Owen from Home Instead and Dr. William Burke from the University of Nebraska Medical Center discuss the latest advancements in treating Alzheimer's disease and other dementias.

Get moral support and Alzheimer’s resources in your Facebook feed by liking our Remember for Alzheimer’s Facebook page.

To find a caregiver in your area, contact your local Home Instead office.